gene_id,gene_symbol,name,in_manning,in_kinmap,in_uniprot_kinasedomain,in_IDG_darkkinases,n_pubmed_citations_2013to2018,pharos_designation,PDB,title,expMethod,deposition_date,last_modification_date,resolution,InChI,InChIKey,chemicalName,smiles,formula,molecularWeight
8445,DYRK2,dual specificity tyrosine phosphorylation regulated kinase 2,1,1,1,1,54,Tchem,5LXD,Crystal structure of DYRK2 in complex with EHT 1610 (compound 2),X-RAY DIFFRACTION,2016-09-20,2017-01-11,2.58,"InChI=1S/C18H14FN5O2S/c1-25-9-3-4-11(10(19)7-9)23-17-14-12(21-8-22-17)5-6-13-15(14)27-18(24-13)16(20)26-2/h3-8,20H,1-2H3,(H,21,22,23)/b20-16+;InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2;InChI=1S/C9H12NO6P/c10-8(9(11)12)5-6-1-3-7(4-2-6)16-17(13,14)15/h1-4,8H,5,10H2,(H,11,12)(H2,13,14,15)/t8-/m0/s1",RYBNARZBIXTFJS-CAPFRKAQSA-N;LYCAIKOWRPUZTN-UHFFFAOYSA-N;DCWXELXMIBXGTH-QMMMGPOBSA-N,"methyl 9-[(2-fluoranyl-4-methoxy-phenyl)amino]-[1,3]thiazolo[5,4-f]quinazoline-2-carboximidate;1,2-ETHANEDIOL;O-PHOSPHOTYROSINE",[H]/N=C(\c1nc2ccc3c(c2s1)c(ncn3)Nc4ccc(cc4F)OC)/OC;C(CO)O;c1cc(ccc1C[C@@H](C(=O)O)N)OP(=O)(O)O,C18 H14 F N5 O2 S;C2 H6 O2;C9 H12 N O6 P,383.399;62.068;261.168
8445,DYRK2,dual specificity tyrosine phosphorylation regulated kinase 2,1,1,1,1,54,Tchem,5LXC,Crystal structure of DYRK2 in complex with EHT 5372 (Compound 1),X-RAY DIFFRACTION,2016-09-20,2017-01-11,2.15,"InChI=1S/C17H11Cl2N5OS/c1-25-15(20)17-24-12-5-4-11-13(14(12)26-17)16(22-7-21-11)23-10-3-2-8(18)6-9(10)19/h2-7,20H,1H3,(H,21,22,23)/b20-15+;InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2;InChI=1S/C9H12NO6P/c10-8(9(11)12)5-6-1-3-7(4-2-6)16-17(13,14)15/h1-4,8H,5,10H2,(H,11,12)(H2,13,14,15)/t8-/m0/s1",QSGKPYRFWJINEH-HMMYKYKNSA-N;LYCAIKOWRPUZTN-UHFFFAOYSA-N;DCWXELXMIBXGTH-QMMMGPOBSA-N,"methyl 9-[(2,4-dichlorophenyl)amino]-[1,3]thiazolo[5,4-f]quinazoline-2-carboximidate;1,2-ETHANEDIOL;O-PHOSPHOTYROSINE",COC(=N)c1nc2ccc3c(c2s1)c(ncn3)Nc4ccc(cc4Cl)Cl;C(CO)O;c1cc(ccc1C[C@@H](C(=O)O)N)OP(=O)(O)O,C17 H11 Cl2 N5 O S;C2 H6 O2;C9 H12 N O6 P,404.273;62.068;261.168
8445,DYRK2,dual specificity tyrosine phosphorylation regulated kinase 2,1,1,1,1,54,Tchem,4AZF,Human DYRK2 in complex with Leucettine L41,X-RAY DIFFRACTION,2012-06-25,2012-11-21,2.55,"InChI=1S/C17H13N3O3/c21-16-13(8-11-6-7-14-15(9-11)23-10-22-14)19-17(20-16)18-12-4-2-1-3-5-12/h1-7,9H,8,10H2,(H,18,20,21);InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2;InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)/p-3;InChI=1S/C9H12NO6P/c10-8(9(11)12)5-6-1-3-7(4-2-6)16-17(13,14)15/h1-4,8H,5,10H2,(H,11,12)(H2,13,14,15)/t8-/m0/s1;InChI=1S/C3H8NO6P/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H2,7,8,9)/t2-/m0/s1",ZDINVWCJHPMIKS-UHFFFAOYSA-N;LYCAIKOWRPUZTN-UHFFFAOYSA-N;NBIIXXVUZAFLBC-UHFFFAOYSA-K;DCWXELXMIBXGTH-QMMMGPOBSA-N;BZQFBWGGLXLEPQ-REOHCLBHSA-N,"5-(1,3-benzodioxol-5-ylmethyl)-2-(phenylamino)-4H-imidazol-4-one;1,2-ETHANEDIOL;PHOSPHATE ION;O-PHOSPHOTYROSINE;PHOSPHOSERINE",c1ccc(cc1)NC2=NC(=O)C(=N2)Cc3ccc4c(c3)OCO4;C(CO)O;[O-]P(=O)([O-])[O-];c1cc(ccc1C[C@@H](C(=O)O)N)OP(=O)(O)O;C([C@@H](C(=O)O)N)OP(=O)(O)O,C17 H13 N3 O3;C2 H6 O2;O4 P -3;C9 H12 N O6 P;C3 H8 N O6 P,307.303;62.068;94.971;261.168;185.072
8445,DYRK2,dual specificity tyrosine phosphorylation regulated kinase 2,1,1,1,1,54,Tchem,3KVW,Crystal Structure of dual-specificity tyrosine phosphorylation regulated kinase 2 (DYRK2) in complex with an indirubin ligand,X-RAY DIFFRACTION,2009-11-30,2011-07-13,2.28,"InChI=1S/ClH/h1H/p-1;InChI=1S/C17H10BrN3O4/c18-10-3-1-2-8-12(16(22)20-13(8)10)15-14(21-25)9-6-7(17(23)24)4-5-11(9)19-15/h1-6,19,25H,(H,20,22)(H,23,24)/b15-12-,21-14+;InChI=1S/C9H12NO6P/c10-8(9(11)12)5-6-1-3-7(4-2-6)16-17(13,14)15/h1-4,8H,5,10H2,(H,11,12)(H2,13,14,15)/t8-/m0/s1;InChI=1S/C3H8NO6P/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H2,7,8,9)/t2-/m0/s1",VEXZGXHMUGYJMC-UHFFFAOYSA-M;UHBJSHHMZNYBAE-HQMCVCOQSA-N;DCWXELXMIBXGTH-QMMMGPOBSA-N;BZQFBWGGLXLEPQ-REOHCLBHSA-N,"CHLORIDE ION;(2Z,3E)-7'-bromo-3-(hydroxyimino)-2'-oxo-1,1',2',3-tetrahydro-2,3'-biindole-5-carboxylic acid;O-PHOSPHOTYROSINE;PHOSPHOSERINE",[Cl-];c1cc\2c(c(c1)Br)NC(=O)/C2=C\3/C(=N/O)/c4cc(ccc4N3)C(=O)O;c1cc(ccc1C[C@@H](C(=O)O)N)OP(=O)(O)O;C([C@@H](C(=O)O)N)OP(=O)(O)O,Cl -1;C17 H10 Br N3 O4;C9 H12 N O6 P;C3 H8 N O6 P,35.453;400.183;261.168;185.072
8445,DYRK2,dual specificity tyrosine phosphorylation regulated kinase 2,1,1,1,1,54,Tchem,3K2L,Crystal Structure of dual-specificity tyrosine phosphorylation regulated kinase 2 (DYRK2),X-RAY DIFFRACTION,2009-09-30,2013-06-26,2.36,"InChI=1S/ClH/h1H/p-1;InChI=1S/Na/q+1;InChI=1S/C9H12NO6P/c10-8(9(11)12)5-6-1-3-7(4-2-6)16-17(13,14)15/h1-4,8H,5,10H2,(H,11,12)(H2,13,14,15)/t8-/m0/s1;InChI=1S/C3H8NO6P/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H2,7,8,9)/t2-/m0/s1;InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2;InChI=1S/C4H10NO6P/c1-2(3(5)4(6)7)11-12(8,9)10/h2-3H,5H2,1H3,(H,6,7)(H2,8,9,10)/t2-,3+/m1/s1",VEXZGXHMUGYJMC-UHFFFAOYSA-M;FKNQFGJONOIPTF-UHFFFAOYSA-N;DCWXELXMIBXGTH-QMMMGPOBSA-N;BZQFBWGGLXLEPQ-REOHCLBHSA-N;QAOWNCQODCNURD-UHFFFAOYSA-L;USRGIUJOYOXOQJ-GBXIJSLDSA-N,CHLORIDE ION;SODIUM ION;O-PHOSPHOTYROSINE;PHOSPHOSERINE;SULFATE ION;PHOSPHOTHREONINE,[Cl-];[Na+];c1cc(ccc1C[C@@H](C(=O)O)N)OP(=O)(O)O;C([C@@H](C(=O)O)N)OP(=O)(O)O;[O-]S(=O)(=O)[O-];C[C@H]([C@@H](C(=O)O)N)OP(=O)(O)O,Cl -1;Na 1;C9 H12 N O6 P;C3 H8 N O6 P;O4 S -2;C4 H10 N O6 P,35.453;22.99;261.168;185.072;96.063;199.099
8445,DYRK2,dual specificity tyrosine phosphorylation regulated kinase 2,1,1,1,1,54,Tchem,5ZTN,The crystal structure of human DYRK2 in complex with Curcumin,X-RAY DIFFRACTION,2018-05-04,2018-08-29,2.5,"InChI=1S/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-13,22,24-25H,1-2H3/b7-3+,8-4-,16-13-;InChI=1S/C9H12NO6P/c10-8(9(11)12)5-6-1-3-7(4-2-6)16-17(13,14)15/h1-4,8H,5,10H2,(H,11,12)(H2,13,14,15)/t8-/m0/s1;InChI=1S/C3H8NO6P/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H2,7,8,9)/t2-/m0/s1",ZIUSSTSXXLLKKK-JXTJPBKQSA-N;DCWXELXMIBXGTH-QMMMGPOBSA-N;BZQFBWGGLXLEPQ-REOHCLBHSA-N,"(1Z,4Z,6E)-5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one;O-PHOSPHOTYROSINE;PHOSPHOSERINE",COc1cc(ccc1O)/C=C/C(=C/C(=O)/C=C\c2ccc(c(c2)OC)O)/O;c1cc(ccc1C[C@@H](C(=O)O)N)OP(=O)(O)O;C([C@@H](C(=O)O)N)OP(=O)(O)O,C21 H20 O6;C9 H12 N O6 P;C3 H8 N O6 P,368.38;261.168;185.072
